Gyre Therapeutics's top three insider shareholders as of March 23, 2026 are Group Ltd. Gni (TenPercentOwner, 64.01Mn shares), Ying Luo (Director, 2.84Mn shares), Songjiang Ma (President, 2.81Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Group Ltd. Gni | 0 | 64,005,887 | 22 Nov, 2023 | |
| Ying Luo | 0 | 2,840,376 | 22 Nov, 2023 | |
| Songjiang Ma | President | 0 | 2,806,084 | 29 May, 2025 |
| Weiguo Ye | Chief Operating Officer | 700,000 | 0 | 14 May, 2025 |
| Eddie Williams | 34,804 | 0 | 07 Jan, 2022 | |
| Geoffrey M.D. Ling | 31,790 | 0 | 07 Jan, 2022 | |
| Errol B Desouza | 29,801 | 0 | 05 Oct, 2021 | |
| Thomas Wilson Eastling | 15,000 | 0 | 18 Apr, 2025 | |
| Grant E. Blouse | Chief Scientific Officer | 9,417 | 0 | 10 Aug, 2022 |
| Nassim Usman | 1,636 | 0 | 01 Jul, 2024 | |
| Howard Levy | Chief Medical Officer | 639 | 0 | 11 Aug, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Jan, 2026 | Ping Zhang | Stock Option (Right to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 07 Jan, 2026 | Ruoyu Chen | Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 18 Aug, 2025 | Dan Weng | Stock Option (Right to Buy) | A | 52,000 | $0.00 | 52,000 | D | A |
| 05 Aug, 2025 | Ping Zhang | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 04 Jun, 2025 | David M. Epstein | Stock Option (Right to Buy) | A | 26,000 | $0.00 | 26,000 | D | A |
| 04 Jun, 2025 | Rodney L Nussbaum | Stock Option (Right to Buy) | A | 26,000 | $0.00 | 26,000 | D | A |
| 04 Jun, 2025 | Renate Parry | Stock Option (Right to Buy) | A | 26,000 | $0.00 | 26,000 | D | A |
| 04 Jun, 2025 | Gordon Carmichael | Stock Option (Right to Buy) | A | 26,000 | $0.00 | 26,000 | D | A |
| 04 Jun, 2025 | Thomas Wilson Eastling | Stock Option (Right to Buy) | A | 26,000 | $0.00 | 26,000 | D | A |
| 27 May, 2025 | Songjiang Ma | Common Stock | D | 2,000 | $10.28 | 2,806,642 | I | S |
| 28 May, 2025 | Songjiang Ma | Common Stock | D | 558 | $10.07 | 2,806,084 | I | S |
| 27 May, 2025 | Ping Zhang | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 22 May, 2025 | Songjiang Ma | Common Stock | D | 2,000 | $10.97 | 2,808,824 | I | S |
| 23 May, 2025 | Songjiang Ma | Common Stock | D | 182 | $10.24 | 2,808,642 | I | S |
| 20 May, 2025 | Songjiang Ma | Common Stock | D | 2,000 | $11.25 | 2,812,824 | I | S |
| 21 May, 2025 | Songjiang Ma | Common Stock | D | 2,000 | $10.83 | 2,810,824 | I | S |
| 16 May, 2025 | Songjiang Ma | Common Stock | D | 2,000 | $11.31 | 2,816,824 | I | S |
| 19 May, 2025 | Songjiang Ma | Common Stock | D | 2,000 | $11.11 | 2,814,824 | I | S |
| 14 May, 2025 | Songjiang Ma | Common Stock | D | 20 | $11.30 | 2,820,824 | I | S |
| 15 May, 2025 | Songjiang Ma | Common Stock | D | 2,000 | $10.68 | 2,818,824 | I | S |